Publikationen in Zusammenarbeit mit Forschern von Universidad Complutense de Madrid (28)

2018

  1. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders

    British Journal of Psychiatry, Vol. 213, Núm. 3, pp. 535-541

2017

  1. Abnormal frontoparietal synaptic gain mediating the P300 in patients with psychotic disorder and their unaffected relatives

    Human Brain Mapping, Vol. 38, Núm. 6, pp. 3262-3276

2016

  1. Elevated midline-parietal gamma band noise power in schizophrenia but not in bipolar patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 8, pp. 743-753

  2. Personality traits in patients with cluster headache: a comparison with migraine patients

    Journal of Headache and Pain, Vol. 17, Núm. 1

2014

  1. Frontal gamma noise power and cognitive domains in schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 221, Núm. 1, pp. 104-113

  2. Gamma power and cognition in patients with schizophrenia and their first-degree relatives

    Neuropsychobiology, Vol. 69, Núm. 2, pp. 120-128

2013

  1. Randomized trial of clozapine vs. risperidone in treatment-naïve first-episode schizophrenia: Results after one year

    Schizophrenia Research, Vol. 149, Núm. 1-3, pp. 156-161

  2. Spatial distribution and cognitive correlates of gamma noise power in schizophrenia

    Psychological Medicine, Vol. 43, Núm. 6, pp. 1175-1185

2012

  1. Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 38, Núm. 2, pp. 270-275

2007

  1. El test de las anillas (TA), un nuevo instrumento para la evaluación de las Funciones Ejecutivas

    Mapfre Medicina, Vol. 18, Núm. SUPPL. 1, pp. 54-63

2005

  1. Dorsolateral prefrontal cortex contribution to abnormalities of the P300 component of the event-related potential in schizophrenia

    Psychiatry Research - Neuroimaging, Vol. 140, Núm. 1, pp. 17-26

2004

  1. An electrophysiological (ERP) component, the recognition potential, in the assessment of brain semantic networks in patients with schizophrenia

    Schizophrenia Research, Vol. 71, Núm. 2-3, pp. 393-404

  2. Long-term olanzapine treatment and P300 parameters in Schizophrenia

    Neuropsychobiology, Vol. 50, Núm. 2, pp. 182-188

2001

  1. Auditory P300 event related potential and serotonin reuptake inhibitor treatment in obsessive-compulsive disorder patients

    Psychiatry Research, Vol. 101, Núm. 1, pp. 75-81

  2. El componente P300 de los potenciales evocados en la valoración de la esquizofrenia: Nuevas evidencias y visiones de futuro

    Revista de Neurologia, Vol. 32, Núm. 3, pp. 250-258

  3. P300 amplitude as a possible correlate of frontal degeneration in schizophrenia

    Schizophrenia Research, Vol. 49, Núm. 1-2, pp. 121-128

1998

  1. Schizophrenic syndromes and clozapine response in treatment-resistant schizophrenia

    Psychiatry Research, Vol. 77, Núm. 1, pp. 21-28

1997

  1. Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: An exploratory 99mTc-HMPAO SPET study

    Schizophrenia Research, Vol. 25, Núm. 1, pp. 11-20

  2. Fronto-striato-thalamic perfusion and clozapine response in treatment- refractory schizophrenic patients. A 99mTc-HMPAO study

    Psychiatry Research - Neuroimaging, Vol. 76, Núm. 1, pp. 51-61

  3. The Wisconsin Card Sorting Test and the assessment of frontal function: A validation study with event related potentials

    Neuropsychologia, Vol. 35, Núm. 4, pp. 399-408